Key result
African-American APOE and TOMM40'523 haplotypes reveal distinct West African admixture and a novel population-specific haplotype.
Observational
Answers are grounded in this paper and cite their sources.
BACKGROUND: Several studies have demonstrated a lower apolipoprotein E4 (APOE ε4) allele frequency in African-Americans, but yet an increased age-related prevalence of AD. An algorithm for prevention clinical trials incorporating TOMM40'523 (Translocase of Outer Mitochondria Membrane) and APOE depends on accurate TOMM40'523-APOE haplotypes. METHODS: We have compared the APOE and TOMM40'523 phased haplotype frequencies of a 9.5 kb TOMM40/APOE genomic region in West African, Caucasian, and African-American cohorts. RESULTS: African-American haplotype frequency scans of poly-T lengths connected in phase with either APOE ε4 or APOE ε3 differ from both West Africans and Caucasians and represent admixture of several distinct West African and Caucasian haplotypes. A new West African TOMM40'523 haplotype, with APOE ε4 connected to a short TOMM40'523 allele, is observed in African-Americans but not Caucasians. CONCLUSION: These data have therapeutic implications for the age of onset risk algorithm estimates and the design of a prevention trial for African-Americans or other mixed ethnic populations.
No takes yet. Share an insight, caveat, or question.
Roses et al. (2014) conducted an observational in Alzheimer's Disease genetic risk factors. African-American ancestry vs. West African and Caucasian ancestry was evaluated on APOE and TOMM40'523 phased haplotype frequencies. African-American APOE and TOMM40'523 haplotypes represent an admixture of West African and Caucasian alleles, featuring a novel West African haplotype not observed in Caucasians.
Synapse has enriched 10 related papers. Consider them for comparative context: